SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001193125-13-251905
Filing Date
2013-06-07
Accepted
2013-06-07 17:18:17
Documents
6

Document Format Files

Seq Description Document Type Size
1 POS AM d551130dposam.htm POS AM 91131
2 EX-4.3 d551130dex43.htm EX-4.3 310273
3 EX-5.1 d551130dex51.htm EX-5.1 28109
4 EX-24.1 d551130dex241.htm EX-24.1 20551
5 GRAPHIC g551130img001.jpg GRAPHIC 3101
6 GRAPHIC g551130img002.jpg GRAPHIC 5632
  Complete submission text file 0001193125-13-251905.txt   463665
Mailing Address 215 FIRST STREET SUITE 7 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 7 CAMBRIDGE MA 02142 617-444-8424
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: OR | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-180258 | Film No.: 13901519
SIC: 2834 Pharmaceutical Preparations